forbes glp 1 How GLP-1 Weight Loss Drugs Have Revolutionized Obesity — Lessons Learned Why China's Oral GLP-1 Drugs
Description
Your care should be, too
Research & Innovation Disclosure STAAR LABS collaborates with clinics, pharmacies, and healthcare professionals to advance innovation in real-world metabolic health protocols
Wang et al conducted a broader meta-analysis of exenatide (twice daily and weekly) and liraglutide studies and estimated a slightly larger BP effect with these agents
Alkhouri N, Herring R, Kabler H, Kayali Z, Hassanein T, Kohli A, et al
Not testimonials
Both medications were originally placed on the FDA's drug shortage list in 2022, which had enabled compounding under the shortage pathway
